METHYS Dx is opening its capital to individuals !
🚀 METHYS Dx is opening its capital to individuals : Our fundraising campaign is now live!
We are thrilled to announce that METHYS Dx has officially opened its equity crowdfunding campaign to the public on Capital Cell! 🚀✨
We are inviting all of you to join us in revolutionizing cancer patient follow-up through innovative liquid biopsy solutions and ensuring that patients receive the precise care they need. 🔬🩺
Cancer is increasingly becoming a chronic disease. With a growing patient population and a rapidly diversifying therapeutic arsenal, the challenge is no longer just detecting cancer, but monitoring treatment efficacy in real-time to adapt care instantly.
Why invest now?
• We aim to bridge the gap in current diagnostics with a breakthrough solution that provides a deeper, more accurate view of disease progression.
• We already commercialize our solution for clinical research, 80% of our clients, clinicians, biologists & researchers, are based in hospitals.
• You are joining us at a pivotal growth stage. This round will accelerate our clinical roadmap and scale our impact in the oncology market.
Join the future of precision medicine 👩‍⚕️🤝
• We believe everyone should have the chance to back the next generation of healthcare: Accessible to all from €1,000
• Securely hosted on Capital Cell
Explore the campaign and join us here: 👉 https://lnkd.in/eUD2SGaW
hashtagHealthTech hashtagOncology hashtagCrowdfunding hashtagImpactInvesting hashtagMethysDx hashtagCapitalCell hashtagInnovation hashtagLiquidBiopsy hashtagBiotech
⚠️ Investing in private companies involves risks, including the total or partial loss of the invested capital and liquidity risks.